Inhibiting the activity of PTP1B prevents and reverses atherosclerotic plaque formation in LDLR−/− mouse model of atherosclerosis, and is associated with a decrease in aortic MCP-1 expression levels, hyperphosphorylation of aortic Akt/PKB and AMPKα. The gene discussed is CCL2; the disease is atherosclerosis.